Canonical Pathway Name | P-value | Ratio |
---|---|---|
Natural killer cell signalling | 3.06 × 10-4 | 23/112 (0.205) |
Communication between innate and adaptive immune cells | 4.11 × 10-4 | 17/89 (0.191) |
TREM1 signalling | 2.20 × 10-3 | 15/69 (0.217) |
Dendritic cell maturation | 4.96 × 10-3 | 29/174 (0.167) |
Cysteine metabolism | 7.43 × 10-3 | 9/90 (0.100) |
JAK/STAT signalling | 8.22 × 10-3 | 15/64 (0.234) |
NRF2-mediated oxidative stress response | 8.98 × 10-3 | 35/183 (0.191) |
T cell receptor signalling | 1.08 × 10-2 | 20/107 (0.187) |
IL6 signalling | 1.52 × 10-2 | 20/93 (0.215) |
CCR5 signalling in macrophages | 1.84 × 10-2 | 16/92 (0.174) |
Chemokine signalling | 1.92 × 10-2 | 15/75 (0.200) |
Calcium-induced T-lymphocyte apoptosis | 2.07 × 10-2 | 12/66 (0.182) |
IL-17 signalling | 2.21 × 10-2 | 16/74 (0.216) |
Prolactin signalling | 2.21 × 10-2 | 16/75 (0.213) |
Synaptic long term potentiation | 2.22 × 10-2 | 19/113 (0.168) |
Toll-like receptor signalling | 2.63 × 10-2 | 11/54 (0.204) |
FLT3 signalling in hematopoietic progenitor cells | 2.77 × 10-2 | 15/74 (0.203) |
Systemic lupus erythematosus signalling | 2.81 × 10-2 | 20/151 (0.132) |
Renin angiotensin signalling | 3.01 × 10-2 | 21/120 (0.175) |
Phospholipase C signalling | 3.28 × 10-2 | 39/253 (0.154) |
Oncostatin M signalling | 3.36 × 10-2 | 9/35 (0.257) |
Thyroid cancer signalling | 3.36 × 10-2 | 9/42 (0.214) |
B cell receptor signalling | 3.72 × 10-2 | 25/154 (0.162) |
Interferon signalling | 3.97 × 10-2 | 6/30 (0.200) |
Production of nitric oxide and reactive oxygen species in macrophages | 4.13 × 10-2 | 28/185 (0.151) |
NF-κB signalling | 4.17 × 10-2 | 25/152 (0.164) |
Notch signalling | 4.29 × 10-2 | 8/43 (0.186) |
IL10 signalling | 4.36 × 10-2 | 13/70 (0.186) |
P38 MAPK signalling | 4.57 × 10-2 | 17/97 (0.175) |
Role of NFAT in regulation of the immune response | 4.70 × 10-2 | 29/196 (0.148) |
Parkinson's signalling | 5.00 × 10-2 | 5/17 (0.294) |